|
|
|
|
|
|
Intersect Ent Cmn (XENT)
|
|
28.70 +0.05 (+0.17%)
|
7/20/2017 12:10pm
|
|
Open:
|
28.75
|
Pre. Close:
|
28.65
|
|
High:
|
28.95
|
Low:
|
28.55
|
|
Volume:
|
72,651
|
Market Cap:
|
825.76M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
28.94 - 29.81
|
29.81 - 30.19
|
|
Low:
|
26.15 - 27.4
|
27.4 - 27.95
|
|
Close:
|
27.25 - 29.07
|
29.07 - 29.86
|
|
|
|
|
|
|
Technical analysis (as of: 2017-07-20 11:33:58 AM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 34.18 One year: 39.92
|
|
Support:
|
Support1: 27.09 Support2: 25.75
|
|
Resistance:
|
Resistance1:
29.26 Resistance2: 34.18
|
|
Pivot:
|
27.94 
|
|
Moving Averages:
|
MA(5): 28.63 MA(20): 27.73
MA(100): 21.53 MA(250): 16.86
|
|
MACD:
|
MACD(12,26):
0.80 Signal(12,26,9): 0.80
|
|
%K %D:
|
%K(14,3): 76.84 %D(3): 79.37
|
|
RSI:
|
RSI(14): 62.61
|
|
52-Week:
|
High: 29.55
Low: 7.65 Change(%): 84.7
|
|
Average Vol(K):
|
3-Month: 41769
10-Days 21875
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.XENT has closed below upper band by 18.4%. Bollinger Bands are 36.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Fri, 14 Jul 2017 20:03:45 GMT
Intersect ENT to Report Second Quarter 2017 Financial Results
Thu, 24 Jul 2014 19:36:06 GMT
27.50
Thu, 20 Jul 2017 14:03:45 GMT
Breaking: Intersect ENT Inc (NASDAQ:XENT) Stock Through Resistance ...
Fri, 24 Feb 2017 13:00:53 GMT
Intersect ENT Announces FDA Approval of Newest Steroid Releasing Implant, PROPEL
Fri, 07 Jul 2017 16:41:15 GMT
Commit To Buy Intersect ENT At $22.50, Earn 15.7% Annualized Using Options
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
